Showing results (51-60 of 142) with videos related to
Sort By:
Pageof 15
AIDS (London, England)|March 18, 2011
Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individualsCristina Mussini, Andrea Cossarizza, Caroline Sabin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 31, 2018
Substantial Heterogeneity in Progress Toward Reaching the 90-90-90 HIV Target in the WHO European RegionKholoud Porter, Annabelle Gourlay, Kathy Attawell, et al.AIDS (London, England)|January 7, 2017
Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infectionGenevieve E Martin, Morgane Gossez, James P Williams, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.Gastroenterology|December 26, 2012
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997Jannie van der Helm, Ronald Geskus, Caroline Sabin, et al.American Journal of Epidemiology|July 30, 2008
Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in womenInmaculada Jarrin, Ronald Geskus, Krishnan Bhaskaran, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention TrialAnne Derache, Collins C Iwuji, Kathy Baisley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2011
Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelinesSara Lodi, Andrew Phillips, Giota Touloumi, et al.AIDS (London, England)|December 5, 2013
Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progressionElizabeth Hamlyn, Sarah Fidler, Wolfgang Stöhr, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohortsGiota Touloumi, Nikos Pantazis, Deenan Pillay, et al.Pageof 15